[EN] PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRIMIDINE UTILISÉS DANS LE TRAITEMENT DU CANCER
申请人:MERCK PATENT GMBH
公开号:WO2016128140A1
公开(公告)日:2016-08-18
Compounds of Formula I or II in which R1, X1 and X2 have the meanings indicated in claim 1, are MTH1 inhibitors and can be employed, inter alia, in the treatment of cancer.
Compounds of Formula I or II
in which R1, X1 and X2 have the meanings indicated in claim
1
, are MTH1 inhibitors and can be employed, inter alia, in the treatment of cancer.